Related Experiment Video
Updated: Mar 25, 2026

Rapid Generation of Amyloid from Native Proteins In vitro
Published on: December 5, 2013
[Amyloidosis: Up-to-date]
1Service de médecine interne, CHRU de Besançon, 3, boulevard Fleming, 25030 Besançon cedex, France; UFR sciences médicales et pharmaceutiques, université de Franche-Comté, rue Claude-Goudimel, 25000 Besançon, France.
Abstract:
Amyloidosis is mainly a systemic disease belonging to protein-folding diseases. The past 10 years have shown significant progress in typing and the clinical management of amyloidosis, in the identification of novel prognostic markers for risk-stratification, and also in the development of new therapeutic agents. Biological molecular techniques are now able to type amyloidosis which were unidentified. Cardiac MRI and biomarkers allow a precise risk-stratification, especially in AL amyloidosis. If necessary, this prognostic evaluation may lead to rapid changes in the chemotherapy treatment. Emerging treatments rely on biotherapies, gene therapy, immunotherapy and blocking analogous agents. They give hope about an increase of survival of patients with systemic amyloidosis.
More Related Videos
10:04Imaging Amyloid Tissues Stained with Luminescent Conjugated Oligothiophenes by Hyperspectral Confocal Microscopy and Fluorescence Lifetime Imaging
Published on: October 20, 2017
08:25Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
Published on: April 19, 2021
Related Concept Videos
Amyloid Fibrils
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Cardiomyopathy IV: Restrictive Cardiomyopathy
Proteoglycans
Lysosomal Hydrolases
Atherosclerosis I: Introduction